Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Ligand Pharmaceuticals

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$15M
Portfolio companies 3
Rounds per year 0.12
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Exits 1
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Therapeutics
  • Biotechnology
  • Health Care
  • Life Science
  • Medical
Summary

In 1987 was created Ligand Pharmaceuticals, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The main office of represented Corporate Investor is situated in the San Diego.

The typical case for the fund is to invest in rounds with 1 participant. Despite the Ligand Pharmaceuticals, startups are often financed by BioAdvance, 13 Ventures.

This Ligand Pharmaceuticals works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The fund is generally included in less than 2 deals every year. The real fund results show that this Corporate Investor is 47 percentage points more often commits exit comparing to other companies. Deals in the range of 5 - 10 millions dollars are the general things for fund. The top amount of exits for fund were in 2015. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Medical, Medical Device. Among the most popular portfolio startups of the fund, we may highlight Palvella Therapeutics, Viking Therapeutics. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups.

Read more

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
3.0 Capital -
Aderans Japan, Tokyo
Brizan Venture -
CEE Group -
Daiwa Logitech Chiba Prefecture, Japan, Tateyama
Elevage Capital Management Dallas, Texas, United States
Fame Mount Limited -
Figment New York, New York, United States
Happy Industry China, Jinan, Shandong
IIFL Special Opportunities Fund -
KARAT Hefa, Hefa, Israel
Neovision Capital China, Shanghai
Net Frontier Japan, Tokyo
New World Private Equity England, London, United Kingdom
Ohio TechAngels Fund -
Provident Growth Fund -
RobecoSAM Switzerland, Zürich, Zurich
Zhaoke Innovation -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Palvella Therapeutics

Biotechnology
Health Care
Life Science
Therapeutics
$45M28 May 2020 Radnor Township, Pennsylvania, United States

Dianomi Therapeutics

Biotechnology
Medical Device
Therapeutics
$3M05 Feb 2019 Colorado, United States

Palvella Therapeutics

Biotechnology
Health Care
Life Science
Therapeutics
$10M18 Dec 2018 Radnor Township, Pennsylvania, United States

Viking Therapeutics

Health Care
Medical
Therapeutics
$2M26 May 2014 San Diego, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Ligand Pharmaceuticals?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: